ACTITHERA NORWAY AS
Operating
Tilby forskningstjenester for utvikling av legemidler innen
radiofarmasi og kreftmedisin.
Utvikling av legemidler innen radiofarmasi og kreftmedisin, samt
virksomhet som naturlig står i forbindelse med dette.
Organization
- Chairman of the board
- AG
- Years since formation
- 1 year
- since Aug 8, 2025
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Financials
- Total operating income 2025
- 4,104,252
- NOK
- Annual total result 2025
- -265,390
- NOK
- Total equity 2025
- -241,890
- NOK
Last update: Jun 2, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
AG | Chairman | - |
| Board Member | - | |
TV 1964 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Jan 18, 2026
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 4,104,252 |
Annual Total Result | -265,390 |
Total assets | 17,520,072 |
Total liabilities | 17,761,962 |
Total equity | -241,890 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 4,104,252 |
Total operating costs | 3,835,420 |
Operating result | 268,832 |
Financial income/costs | -534,222 |
Profit before tax | -265,390 |
Total tax & extraordinary income/cost | 0 |
Annual Total Result | -265,390 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 1,393,733 |
Total current assets | 16,126,340 |
Total assets | 17,520,072 |
Short term debt | 17,761,962 |
Long term debt | 0 |
Total liabilities | 17,761,962 |
Contributed capital | 30,000 |
Retained earnings | -271,890 |
Total equity | -241,890 |
Total equity and liabilities | 17,520,072 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises